We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$882M
AUM Growth
+$126M
Cap. Flow
+$66.7M
Cap. Flow %
7.55%
Top 10 Hldgs %
34.21%
Holding
2,922
New
175
Increased
1,422
Reduced
927
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Healthcare 8%
3 Financials 7.49%
4 Consumer Staples 6.68%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFS icon
2576
Provident Financial Services
PFS
$3.12B
$812 ﹤0.01%
38
-219
-85% -$4.7K
SILK
2577
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$793 ﹤0.01%
15
+2
+15% +$97
DHC
2578
Diversified Healthcare Trust
DHC
$2.26B
$791 ﹤0.01%
1,223
-11,734
-91% -$11.6K
BHM icon
2579
Bluerock Homes Trust
BHM
$35.3M
$788 ﹤0.01%
+37
New +$865
MDXG icon
2580
MiMedx Group
MDXG
$651M
$776 ﹤0.01%
+279
New +$834
KOS icon
2581
Kosmos Energy
KOS
$1.45B
$770 ﹤0.01%
121
CATO icon
2582
Cato Corp
CATO
$63.9M
$765 ﹤0.01%
82
RMNI icon
2583
Rimini Street
RMNI
$437M
$758 ﹤0.01%
+199
New +$884
SB icon
2584
Safe Bulkers
SB
$760M
$748 ﹤0.01%
257
LAW icon
2585
CS Disco
LAW
$253M
$733 ﹤0.01%
+116
New +$991
ASPN icon
2586
Aspen Aerogels
ASPN
$384M
$731 ﹤0.01%
62
-130
-68% -$1.49K
ONT
2587
Onterris Inc
ONT
$720M
$710 ﹤0.01%
+16
New +$677
GTHX
2588
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$706 ﹤0.01%
+130
New +$1.09K
SCHD icon
2589
Schwab US Dividend Equity ETF
SCHD
$103B
$679 ﹤0.01%
27
CRK icon
2590
Comstock Resources
CRK
$3.82B
$672 ﹤0.01%
49
+24
+96% +$410
LEGN icon
2591
Legend Biotech
LEGN
$3.67B
$649 ﹤0.01%
13
+5
+63% +$242
PHR icon
2592
Phreesia
PHR
$662M
$647 ﹤0.01%
20
-19
-49% -$516
LEG icon
2593
Leggett & Platt
LEG
$1.51B
$645 ﹤0.01%
20
-1
-5% -$34
BBBY
2594
DELISTED
Bed Bath & Beyond Inc
BBBY
$638 ﹤0.01%
254
-2,254
-90% -$8.85K
SPOT icon
2595
Spotify
SPOT
$102B
$632 ﹤0.01%
8
-163
-95% -$13.1K
NTLA icon
2596
Intellia Therapeutics
NTLA
$1.51B
$628 ﹤0.01%
18
-148
-89% -$7.04K
LKFT
2597
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$621 ﹤0.01%
14
-354
-96% -$14.9K
SCHH icon
2598
Schwab US REIT ETF
SCHH
$11.7B
$617 ﹤0.01%
32
ETNB
2599
DELISTED
89bio
ETNB
$611 ﹤0.01%
+48
New +$432
ATEN icon
2600
A10 Networks
ATEN
$2.43B
$599 ﹤0.01%
+36
New +$617

Similar funds

Quadrant Capital Group's Q4 2022 Portfolio in Review

As of Q4 2022, Quadrant Capital Group held 2,922 positions worth $882M, up 17% from $756M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group deployed $66.7M of net new capital in Q4 2022, opening 175 new positions and adding to 1,422 existing holdings. Its largest new stake was Vanguard International High Dividend Yield ETF: 6,252 shares worth $372K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $7.2M trimmed.

  • Quadrant Capital Group's largest Q4 2022 buy was Vanguard International High Dividend Yield ETF: 6,252 shares worth $372K.
  • Quadrant Capital Group added most to Vanguard Short-Term Bond ETF in Q4 2022, an estimated $25.7M increase.
  • Quadrant Capital Group's biggest Q4 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $7.2M.
  • Quadrant Capital Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $393K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $882M portfolio in Q4 2022.
  • Quadrant Capital Group opened 175 new positions and closed 190 in Q4 2022.
  • Quadrant Capital Group's portfolio value rose 17% quarter-over-quarter to $882M.

Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.